A generation of human induced pluripotent stem cell line (MUi031-A) from a type-3 Gaucher disease patient carrying homozygous mutation on GBA1 gene

Stem Cell Res. 2022 Apr:60:102698. doi: 10.1016/j.scr.2022.102698. Epub 2022 Feb 2.

Abstract

Gaucher disease (GD) is one of the most prevalent lysosomal storage diseases caused by mutation of glucocerebrosidase (GBA1) gene. GD patients develop symptoms in various organs of the body; however, the underlying mechanisms causing pathology are still elusive. Thus, a suitable disease model is important in order to facilitate subsequent investigations. Here, we established MUi031-A human induced pluripotent stem cell (hiPSC) line from CD34+ hematopoietic stem cells of a female type-3 GD patient with homozygous c.1448 T > C (L444P) mutation. The cells exhibited embryonic stem cell-like characteristics and expressed pluripotency markers with capability to differentiate into three germ layers.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Female
  • Gaucher Disease* / metabolism
  • Glucosylceramidase / genetics
  • Glucosylceramidase / metabolism
  • Homozygote
  • Humans
  • Induced Pluripotent Stem Cells* / metabolism
  • Mutation / genetics

Substances

  • Glucosylceramidase